Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of Tissue and Blood Collection in Oncogene-addicted and Neoadjuvantly Treated Non Small Cell Lung Cancer

NCT07008742 is registered in ClinicalTrials.gov with Royal Marsden NHS Foundation Trust as lead sponsor.

NCT NCT07008742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07008742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of Tissue and Blood Collection in Oncogene-addicted and Neoadjuvantly Treated Non Small Cell Lung Cancer
Lead sponsor
Royal Marsden NHS Foundation Trust
Phase
Observational
Overall status
Recruiting
Start date
June 4, 2025
Completion date
June 1, 2029
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early-stage operable non small cell lung cancer, locally advanced nsclc - non-small cell lung cancer, metastatic non small cell lung cancer, non small cell lung cancer, oncogene-addicted non small cell lung cancer, stage 2/3 operable non small cell lung cancer